Icahn School of Medicine at Mount Sinai Researcher Updates Knowledge of Psoriasis (Once-daily roflumilast foam 0.3% for scalp and body psoriasis: A randomized, double-blind, vehicle-controlled phase 2b study)

Press/Media

Period	27 Jun 2023

Media coverage

Title	Icahn School of Medicine at Mount Sinai Researcher Updates Knowledge of Psoriasis (Once-daily roflumilast foam 0.3% for scalp and body psoriasis: A randomized, double-blind, vehicle-controlled phase 2b study)
Media name/outlet	Clinical Trials Daily
Country/Territory	United States
Date	27/06/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=68JT-80F1-DY7R-R2FH-00000-00
Persons	Leon Kircik